Reply to: Tumor Site Heterogeneity in OrigAMI-4: Biological Implications and Open Questions for OrigAMI-5
Journal of Clinical Oncology · 17.11.2026
DOI: 10.1200/jco-26-02504 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Oncology, online erschienen am 17.11.2026. Verfasst von Barbara Burtness und 3 weiteren Autor:innen. Beteiligte Einrichtung: Barbara Burtness, MD, Department of Internal Medicine and Yale Cancer Center, Yale School of Medicine, New Haven, CT; Kiichiro Toyoizumi, PhD, Johnso…. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Barbara Burtness, MD, Department of Internal Medicine and Yale Cancer Center, Yale School of Medicine, New Haven, CT; Kiichiro Toyoizumi, PhD, Johnson & Johnson, Tokyo, Japan; Emrullah Yilmaz, MD, PhD, Johnson & Johnson…
ORCID-Profile: Barbara Burtness, Kiichiro Toyoizumi, Emrullah Yilmaz, Kevin J Harrington
Zitieren
APA
Burtness, B., Toyoizumi, K., Yilmaz, E., & Harrington, K. J. (2026). Reply to: Tumor Site Heterogeneity in OrigAMI-4: Biological Implications and Open Questions for OrigAMI-5. Journal of Clinical Oncology. https://doi.org/10.1200/jco-26-02504
Vancouver
Burtness B, Toyoizumi K, Yilmaz E, Harrington KJ. Reply to: Tumor Site Heterogeneity in OrigAMI-4: Biological Implications and Open Questions for OrigAMI-5. Journal of Clinical Oncology. 2026. doi:10.1200/jco-26-02504
BibTeX
@article{Burtness2026,
author = {Burtness, Barbara and Toyoizumi, Kiichiro and Yilmaz, Emrullah and Harrington, Kevin J},
title = {Reply to: Tumor Site Heterogeneity in OrigAMI-4: Biological Implications and Open Questions for OrigAMI-5},
journal = {Journal of Clinical Oncology},
year = {2026},
doi = {10.1200/jco-26-02504}
}
EUVIMED